. Amin, Nussbaumer et al, 2003.

. Amin, , 2009.

. Paci, , 2015.

. Bourget, , 2001.

. Bourget, , 2003.

. Bouligand, , 2005.

A. Amin, P. Bouget, F. Vidal, and F. Ader, Routine application of Raman spectroscopy in the quality control of hospital compounded ganciclovir, Int J Pharm, vol.474, pp.193-201, 2014.

, Arrêté du 6 avril 2011 relatif au management de la qualité de la prise en charge médicamenteuse et aux médicaments dans les établissements de santé JORF n°0090 du 16 avril 2011 page 6687 texte n° 14

L. Ashley, R. Dexter, F. Marshall, B. Mckenzie, M. Ryan et al., Improving the Safety of Chemotherapy Administration: An Oncology Nurse-Led Failure Mode and Effects Analysis, Oncol Nurs Forum, vol.38, pp.436-480, 2011.

F. Basuyau and P. Brunelle, Comparaison de deux mesures physiques rapides pour le contrôle de la dose des préparations injectables de médicaments anticancéreux avant administration : application au 5-fluorouracile, J Pharm Clin, vol.19, pp.5-9, 2000.

C. Bazin, V. Vieillard, A. Astier, and M. Paul, Contrôle rapide et fiable des préparations de chimiothérapies à base d'anticorps monoclonaux à l'aide de l'automate Multispec ®, Ann Pharm Fr, vol.68, pp.163-77, 2010.

C. Bazin, V. Vieillard, A. Astier, and M. Paul, Implementation of real-time identification analysis and quantification of chemotherapies preparations with a Multispec ® analyser, Ann Pharm Fr, vol.72, pp.33-40, 2014.

C. Bazin, B. Cassard, E. Caudron, P. Prognon, and L. Havard, Comparative analysis of methods for real-time analytical control of chemotherapies preparations, Int J Pharm, vol.494, pp.329-365, 2015.

F. Benizri, B. Dalifard, C. Zemmour, M. Henriquet, E. Fougereau et al., DrugCam ® -An intelligent video camera system to make safe cytotoxic drug preparations, Int J Pharm, vol.502, pp.198-207, 2016.

B. Bonan, N. Martelli, M. Berhoune, M. L. Maestroni, L. Havard et al., The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs, Int J Qual Health Care, vol.21, pp.44-50, 2009.

P. Bonnabry, L. Cingria, M. Ackermann, F. Sadeghipour, L. Bigler et al., Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process, Int J Qual Health Care, vol.18, pp.9-16, 2006.

J. Bouligand, A. Paci, L. Mercier, G. Vassal, and P. Bourget, High-performance thinlayer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical products, J Pharm Biomed Anal, vol.34, pp.525-555, 2004.

J. Bouligand, T. Storme, I. Laville, L. Mercier, O. Oberlin et al., Quality control and stability study using HTPLC: applications to cyclophosphamide in various pharmaceutical products, J Pharm Biomed Anal, vol.38, pp.180-185, 2005.

P. Bourget, L. Perello, and S. Demirdjian, Place et spectre fonctionnel de l'HTPLC dans un programme d'assurance qualité pharmaceutique hospitalier, Pathol Biol, vol.49, pp.86-95, 2001.

P. Bourget, A. Paci, J. B. Rey, L. Mercier, and S. Demirdjian, Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unit, Eur J Pharm Biopharm, vol.56, pp.445-51, 2003.

P. Bourget, A. Moriceau, B. Cassard, F. Vidal, and R. Clement, La spectroscopie Raman (SR) : un nouvel outil adapté au contrôle de qualité analytique des préparations injectables en milieu de soins. Comparaison de la SR aux techniques CLHP et UV/Visible-IRFT appliquée à la classe des anthracyclines en cancérologie, Pathol Biol, vol.60, pp.369-79, 2012.

P. Bourget, A. Amin, F. Vidal, C. Merlette, and F. Lagarce, Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: Model of elastomeric portable pumps filled with a fluorouracil solution, J Pharm Biomed Anal, vol.91, pp.176-84, 2014.

P. Bourget, A. Amin, F. Vidal, C. Merlette, P. Troude et al., The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: Eliminating the exposure risks for staff members and their work environment, Int J Pharm, vol.470, pp.70-76, 2014.

K. Buckley and P. Matousek, Recent advances in the application of transmission Raman spectroscopy to pharmaceutical analysis, J Pharm Biomed Anal, vol.55, pp.645-52, 2011.

C. Butts, S. Kamel-reid, G. Batist, and S. Chia, Benefits, issues, and recommendations for personalized medicine in oncology in Canada, Curr Oncol, vol.20, pp.475-83, 2013.

R. Cairns, J. A. Brown, A. M. Lynch, J. Robinson, C. Wylie et al., A decade of Australian methotrexate dosing errors, Med J Aust, vol.204, p.384, 2016.

L. Carrez, L. Falaschi, L. Cingria, F. Sadeghipour, L. Bouchoud et al., Organisation et sécurisation du circuit des chimiothérapies : Exemple de la pharmacie des, Pharmactuel, vol.47, pp.119-124, 2014.

W. H. Chen, L. J. Hen, R. J. Guan, and F. L. Wu, Assessment of an automatic robotic arm for dispensing of chemotherapy in a 2500-bed medical center, J Formosan Med Assoc, vol.112, pp.193-200, 2013.

C. Chia-hui, C. Chia-jen, P. , W. Hsi-yen, L. et al., Applying HFMEA to Prevent Chemotherapy Errors, J Med Syst, vol.36, pp.1543-51, 2012.

M. Christine, Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve safety, Int J Qual Health Care, vol.23, pp.36-43, 2011.

M. Ciofi-degli-atti, V. Paolini, M. Cavallin, T. Corsetti, F. Locatelli et al., Proactive evaluation of clinical risk: a FMECA analysis in pediatric chemotherapy, Nuovi Ann Ig Microbiol, vol.25, pp.15-21, 2013.

K. E. Covinsky, R. M. Palmer, R. H. Fortinsky, S. R. Counsell, A. L. Stewart et al., Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age, J Am Geriatr Soc, vol.51, pp.451-458, 2003.

A. Delmas, J. B. Gordien, J. M. Bernadou, M. Roudaut, A. Gresser et al., Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in centralized parenteral preparations unit, J Pharm Biomed Anal, vol.49, pp.1213-1220, 2009.

M. J. Facchinetti, G. M. Campbell, and D. P. Jone, Evaluating dispensing error detection rates in a hospital pharmacy, Med Care, vol.37, pp.39-43, 1999.

A. Fyhr and R. Akslsson, Characteristics of medication errors with parenteral cytotoxic drugs, Eur J Cancer Care, vol.21, pp.606-613, 2012.

N. Guichard, M. Ogereau, L. Falaschi, S. Rudaz, J. Schappler et al., Determination of 16 antineoplastic drugs by capillary electrophoresis with UV detection: applications in quality control electrophoresis, 2018.

E. Gravel, P. Bourget, L. Mercier, and A. Paci, Fluorescence detection combined with either HPLC or HPTLC for pharmaceutical quality control in a hospital chemotherapy production unit: Application to camptothecin derivatives, J Pharm Biomed Anal, vol.39, pp.581-586, 2005.

, Institute for Safe Medication Practices. «ISMP's List of High-Alert Medications ». Institute for safe medications practices, 2017.

T. Iwamoto, T. Morikawa, M. Hioki, H. Sudo, D. Paolucci et al., Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital, J Pharm Health Care Sci, vol.3, pp.12-13, 2017.

E. Kathleen, M. Kathleen, R. Douglas, C. B. , and J. L. , Multisite parent-centered risk assessment to reduce pediatric oral chemotherapy errors, J Oncol Pract, vol.9, pp.1-7, 2013.

P. Lago, G. Bizzarri, F. Scalzotto, A. Parpaiola, A. Amigoni et al., Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards: a quality improvement report, BMJ, vol.2, p.1249, 2012.

L. Garlantezec, P. Aupee, O. Bohand, X. Paillet, M. Dassé et al., Choix et mise en place d'un contrôle pondéral libératoire au sein d'une unité hospitalière centralisée de préparation des cytotoxiques, Le Pharmacien Hospitalier, vol.43, pp.19-27, 2008.

L. M. Lê, E. Caudron, A. Baillet-guffroy, and L. Eveleigh, Non-invasive quantification of 5 fluorouracil and gemcitabine in aqueous matrix by direct measurement through glass vials using near-infrared spectroscopy, Talanta, vol.119, pp.361-366, 2014.

J. Lecordier, Y. Heluin, C. Plivard, A. Bureau, C. Mouawad et al., Safety in the preparation of cytotoxic drugs: How to integrate gravimetric control in the quality assurance policy, Biomed Pharmacother, vol.65, pp.17-21, 2011.

S. Limat, J. P. Drouhin, K. Demesemay, E. Tissot, M. Jacquet et al., Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit, Pharm World Sci, vol.23, pp.102-106, 2001.

T. O. Mattsson, B. Holm, H. Michelsen, J. L. Knudsen, K. Brixen et al., Non-intercepted dose errors in prescribing anti-neoplastic treatment: a prospective, comparative cohort study, Ann Oncol, vol.26, pp.981-986, 2015.

M. S. Mcdonagh, D. H. Smith, and M. Goddard, Measuring appropriate use of acute beds. A systematic review of methods and results, Health Policy, vol.53, pp.157-184, 2000.

, Consultable at, 2017.

M. Moretti, M. G. Grollino, S. Pavanello, R. Bonfiglioli, M. Villarini et al., Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach, Int Arch Occup Environ Health, vol.88, pp.683-695, 2015.

F. Nardella, M. Beck, P. Collart-dutilleul, G. Becker, C. Boulanger et al., A UV-Raman spectroscopy method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy, Int J Pharm, vol.499, pp.343-350, 2016.

S. Nussbaumer, S. Fleury-souverain, P. Antinori, F. Sadeghipour, D. F. Hochstrasser et al., Simultaneous quantification of ten cytotoxic drugs by a validated LC-ESI-MS/MS method, Anal Bioanal Chem, vol.398, pp.3033-3042, 2010.

S. Nussbaumer, P. Bonnabry, J. L. Veuthey, and S. Fleury-souverain, Analysis of anticancer drugs: A review, Talanta, vol.85, pp.2265-2289, 2011.

Z. Nurgat, D. Faris, M. Mominah, A. Vibar, A. Al-jazairi et al., A three-year study of a first-generation chemotherapy-compounding robot, Am J Health-Syst Pharm, vol.72, pp.1036-1045, 2015.

A. Paci, L. Mercier, and P. Bourget, Identification and quantification of antineoplastic compounds in chemotherapeutic infusion bags by use of HTPLC: application to the vinca-alkaloids, J Pharm Biomed Anal, vol.30, pp.1603-1610, 2003.

E. Palma and C. Bufarini, Robot-assisted preparation of oncology drugs: The role of nurses, Int J Pharm, vol.439, pp.286-288, 2012.

B. J. Peters, M. A. Capelle, T. Arvinte, and E. M. Van-de-garde, Validation of an automated method for compounding monoclonal antibody patient doses, mAbs, vol.5, pp.162-170, 2013.

M. Petit, C. Curti, M. Roche, M. Montana, C. Bornet et al., Environmental monitoring by surface sampling for cytotoxics: a review, Environmental Monitoring and Assessment, vol.189, pp.52-66, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01433551

, the Development of Personalized Medicine in Oncology: Workshop Summary.Institute of Medicine (US), 2010.

S. Pongudom and Y. Chinthammitr, Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature, J Med Assoc Thailand, vol.94, pp.258-263, 2011.

F. Ranchon, G. Salles, H. M. Späth, V. Schwiertz, N. Vantard et al., Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs, BMC Cancer, vol.11, p.478, 2011.

P. V. Rekhadevi, N. Sailaja, M. Chandrasekhar, M. Mahboob, M. F. Rahman et al., Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs, Mutagenesis, vol.22, pp.395-401, 2007.

D. L. Robinson, M. Heigham, and J. Clark, Using failure mode and effects analysis for safe administration of chemotherapy to hospitalized children with cancer, Jt Comm J Qual Patient Saf, vol.32, pp.161-166, 2006.

M. Sasaki, N. Ishii, Y. Kikuchi, Y. Kudoh, R. Sugiyama et al., Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and ?-fluoro-?-alanine in urine, Sangyo Eiseigaku Zasshi, pp.58164-72, 2016.

R. Schierl, C. Masini, S. Groeneveld, E. Fischer, A. Böhlandt et al., Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo, J Oncol Pharm Pract, vol.22, pp.37-45, 2016.

A. Seger, W. Churchill, C. Keohane, C. Belisle, S. Wong et al., Impact of robotic antineoplastic preparation on safety, workflow, and costs, J Oncol Pharm Pract, vol.8, pp.344-349, 2012.

P. J. Sessink, G. M. Leclercq, D. M. Wouters, L. Halbardier, C. Hammad et al., Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation, J Oncol Pharm Pract, vol.21, pp.118-127, 2015.

K. G. Shojania, B. W. Duncan, K. M. Mcdonald, and R. M. Wachter, Safe but sound: patient safety meets evidence-based medicine, JAMA, vol.288, pp.508-513, 2002.

C. Sottani, B. Porro, M. Imbriani, and C. Minoia, Occupational exposure to antineoplastic drugs in four Italian health care settings, Toxicol Lett, vol.213, pp.107-115, 2012.

, Synthèse nationale des bilans à un an des 35 sites pilotes. Résultats des expérimentations du parcours personnalisé des patients. INCa, octobre 2012. Available on www, 2017.

G. Tournel, A. Bécart-robert, P. Courtin, V. Hédouin, and D. Gosset, Fatal accidental intrathecal injection of vindesine, J Forensic Sci, vol.51, pp.1166-1168, 2006.

A. Ulas, K. Silay, S. Akinci, D. S. Dede, M. B. Akinci et al., Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey, Asian Pac J Cancer Prev, vol.16, pp.1699-1705, 2015.

C. M. Van-tilburg, I. P. Leistikow, C. M. Rademaker, and M. B. Bierings, Van Dijk AT (2006) Health care failure mode and effect analysis: a useful proactive risk analysis in a pediatric oncology ward, Qual Saf Health Care, vol.15, pp.58-64

S. N. Weingart, J. Toro, J. Spencer, D. Duncombe, A. Gross et al., Medication errors involving oral chemotherapy, Cancer, vol.116, pp.2455-2464, 2010.

A. W. Yaniv and S. J. Knoer, Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy, Am J Health-Syst Pharm, vol.70, pp.2030-2037, 2013.